Clinical Trial: Forecasting Occult liveR Metastasis Using an Exosomal Signature for Intelligent Guided Hepatic Targeting
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: PDAC - Pancreatic Ductal Adenocarcinoma
Study Type: OBSERVATIONAL
Official Title: An Exosome-based Liquid Biopsy Signature for Preoperative Identification of Occult Liver Metastasis in Patients With Pancreatic Ductal Adenocarcinoma
Brief Summary:
Early liver metastasis (Early-LiM) is the most significant prognostic factor in pancreatic ductal adenocarcinoma (PDAC) and is thought to originate from occult micrometastases present at the time of surgery.Reliable preoperative detection of such lesions remains an unmet clinical need.The EXELiM study aims to develop and validate a circulating exosomal microRNA (exo-miRNA)-based liquid biopsy assay to accurately identify PDAC patients at high risk of occult liver metastasis before surgery.By integrating machine…
Read more